A lot of the papers looking at these drugs and their impact on immunity have shown that people who take them respond better to infections, they have better outcomes in the context of fighting different types of cancer, but no one has looked at what is directly happening to the immune cells, says Claire Pillsbury, PhD, a postdoctoral fellow working in the lab of cancer center leader Curtis Henry, PhD
Thyroid concerns arose during drug development due to C-cell hyperplasia and medullary thyroid carcinoma seen in rodent studies
Calming Blends products are not intended to diagnose, treat, cure, or prevent any disease
Individuals with a BMI over 25 and metabolic concerns, or a BMI over 30, may be eligible following a medical evaluation
Svetlana Mojsov , working at the Endocrine Unit and head of the HHMI peptide synthesis facility at Mass General Hospital, later identified the active form of intestinal GLP-1 to be GLP-1 (7-37)